Shilling
Campo Grande, 28 3º B, Lisbon, Lisboa, 1700, Portugal
Overview
Shilling is an early-stage venture capital firm backing exceptional founders from the start. Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, direct access to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
- Total investments
- 43
- Lead investments
- 12
- Investments · 12mo
- 6
- Active investors
- 9
Sector focus
- Venture Capital
Investment portfolio
- Luca
Participated · Series A · Aug 2026
Luca offers a broad catalogue of high-quality curricular content across courses and subjects combined with AI tools designed to reduce teachers’ administrative time. The company emphasizes competitive pricing, operational excellence, transparent contracts and a strong customer experience. Coverage describes Luca as one of the fastest-growing edtech companies in Latin America and as a top-decile SaaS company at the Series A stage globally. Its product approach blends traditional learning elements with AI to enable individualized, scalable blended education that complements teachers. Financially, the company has raised over $13 million in total funding following the $8 million Series A. The article frames Luca’s strategy as long-term, aiming to build a durable company rather than chase a short-term trend.
- Balance
Led · Seed · Jul 2026
Balance operates a digital platform that connects patients with obesity to an independent multidisciplinary team of doctors, nutritionists, exercise specialists and psychologists through its Método Balance®. The program treats obesity as a chronic disease and is built around four pillars: medicine, nutrition, exercise and emotional support delivered via the Balance app. Its primary revenue model is B2C subscriptions that give patients continuous access to professional follow-up, and the platform enables clinicians to prescribe GLP-1–based medications such as Wegovy and Mounjaro as part of care. Balance emphasizes coordinated, continuous care versus intermittent in-person visits and leverages digital tools and data analysis to improve adherence and effectiveness. The company has a team of about 10 people, an architecture designed to be adaptable for other markets, and is preparing to scale both domestically and internationally while developing B2B channels with employers, insurers and healthcare organizations.
- Tucuvi
Participated · Series A · Jan 2026
Tucuvi offers an AI Care Management platform built around conversational agents such as LOLA, a voice-AI that conducts patient phone calls, executes clinical workflows, and escalates cases to human staff when necessary. The system currently supports more than 50 care workflows, including post-surgical follow-ups, chronic-care management, screenings, scheduling, and medication adherence. According to the company, its technology has already completed over 300,000 patient calls and is deployed in more than 60 healthcare organizations across Europe. By automating documentation and integrating with existing health-system operations, Tucuvi aspires to ease staffing pressures while maintaining clinical quality. Founded by CEO María González after a personal experience with a hospital error, the firm positions safety, auditability, and regulatory compliance as core design principles. With fresh funding, Tucuvi plans to accelerate expansion throughout Europe and enter the U.S. market. Prior to the latest raise, it had secured between $3 million and $3.5 million in earlier funding.
- Punto Health
Participated · Seed · Dec 2025
Punto Health is developing a dementia care platform that combines speech-based digital biomarkers with personalized daily care plans and clinician dashboards to shift cognitive care toward earlier identification and proactive, day-to-day support. The system forms a connected ecosystem that guides patients and carers while streamlining monitoring and care coordination for clinicians. Over the past year, the team co-designed and clinically validated the product with partners such as Ace Alzheimer Center Barcelona, several NHS Foundation Trusts, and multiple Spanish hospitals, reaching more than 2,000 individuals in the process. Feedback from these patients, carers, and clinicians has shaped product features aimed at usability and continuous engagement. With fresh seed capital, the company plans to scale its technology, expand hiring in London and Barcelona, and widen access to proactive dementia care for additional families. Financially, Punto Health has secured $2.7 million to fund these growth initiatives. The company is led by co-founder and CEO Anna Muñoz Farré.
- Algori
Participated · Equity · Dec 2025
Algori is a Madrid-based purchase and behavioural data platform serving the fast-moving consumer goods (FMCG) sector. It collects physical and digital receipts through its consumer apps and uses a proprietary AI classification engine to transform every line item into SKU-level, retailer-specific data. The resulting dataset gives manufacturers and retailers timely visibility into full basket composition, store-level pricing shifts, purchase missions and shopper leakage, filling the gaps left by traditional household panels of 4,000–20,000 participants. Customers use Algori’s insights to inform distribution, pricing, promotions, assortment and category strategies across increasingly consolidated European retail markets. The company plans to expand its shopper panel into Poland, Germany and France, followed by Latin America, while also broadening behavioural data collection and rolling out new AI-driven insight tools. Including the latest growth capital round, Algori has raised a total of €7.5 million to date.